Contacts

MedinCell announces the initiation of coverage of its stock by ODDO-BHF

July 26, 2021

The initiation of coverage realized by ODDO-BHF on July 20, 2021, with a study entitled “First approval and launch expected in 2022”, strengthens the visibility of the MedinCell share among French and international institutional investors.

This coverage comes in addition to those already carried out by the brokerage firms Bryan Garnier and Kepler Cheuvreux.

Session en français

Mardi 19 décembre, 18h30 : Présentation des résultats du premier semestre de l'année fiscale 2023-24

English session

Tuesday, December 19, 6:30 pm: Half-year earnings call (April 1st - September 30th)

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.